Showing 4471-4480 of 9406 results for "".
- Almirall to Present New Drug Data at EADVhttps://practicaldermatology.com/news/almirall-present-new-drug-data-eadv/2468258/Almirall will present 34 abstracts detailing the latest research on lebrikizumab for moderate-to-severe atopic dermatitis in adolescents and adults and tildrakizumab and Almirall’s CAL/BDP cream for moderate-to-severe plaque psoriasis in adults at the 33rd Congress of the European Academy of Derm
- NJ Legislator Pushes to Allow Sunscreen in Schoolshttps://practicaldermatology.com/news/nj-legislator-pushes-allow-sunscreen-schools/2468244/A new bill referred to New Jersey’s Assembly Education Committee would make the Garden State the 29th to pass legislation allowing direct access to sunscreen in schools, according to Insider NJ. Sunscreen is classified by the US Food and Drug Administration (FDA) as an over-the-counter dru
- Study Links Psoriasis to NMSC in Womenhttps://practicaldermatology.com/news/study-links-psoriasis-nmsc-women/2468243/Psoriasis was associated with a higher risk of nonmelanoma skin cancer in women in a new study published in Nature Communications. “An observational and genetic investigation into the association between psoriasis and risk of malignancy” found higher risks of a total of 16 types of cancer
- EADV Presentation to Highlight New IL-13/IL-31 Bispecific Antibodyhttps://practicaldermatology.com/news/eadv-presentation-highlight-new-il-13il-31-bispecific-antibody/2468228/Data from a preclinical study of ZL-1503, an IL-13/IL-31 bispecific antibody for the treatment of atopic dermatitis (AD), will be presented in a late-breaking oral presentation at the European Academy of Dermatology and Venerology Congress (EADV) 2024 taking place September 25-28 in Amsterdam, Ne
- Researchers Analyze Social Media Posts on JAK Inhibitorshttps://practicaldermatology.com/news/researchers-analyze-social-media-posts-jak-inhibitors/2468227/An analysis of social media posts concluded that patients are most concerned about the efficacy and side effects of JAK inhibitors and issues regarding access to them, according to a new Archive of Dermatological Research article by members of the University of Nebraska Medical Center’s Departmen
- Cord Blood Biomarkers and TEWL Predict Atopic Dermatitis in Infantshttps://practicaldermatology.com/news/cord-blood-biomarkers-and-tewl-predict-atopic-dermatitis-infants/2468171/A prospective study reports that elevated levels of CCL17 and IL-31 in cord blood, along with increased transepidermal water loss (TEWL) at the anterior cubital fossa, could help identify infants at higher risk of developing atopic dermatitis (AD) within their first year of life. The study
- Study Identifies Key Patient-Centered Attributes of Atopic Dermatitis Flarehttps://practicaldermatology.com/news/study-identifies-key-patient-centered-attributes-ad-flare/2468156/A new study revealed a consensus on the patient-centered definition of an atopic dermatitis (AD) flare. Researchers for the study recruited 26 participants for focus groups and 631 participants for a survey through the National Eczema Association. The participants rated various attributes
- Tralokinumab Safe for Special Atopic Dermatitis Populationshttps://practicaldermatology.com/news/tralokinumab-found-safe-special-ad-populations/2468141/A recent retrospective study indicated that tralokinumab was linked with significant improvements in atopic dermatitis (AD) in special populations (SPs) such as the elderly and those with significant comorbidities. Researchers investigating the efficacy and safe
- CHE Studies Presented at ESCD 2024 Congresshttps://practicaldermatology.com/news/che-studies-presented-escd-2024-congress/2468089/LEO Pharma A/S presented a range of new population-level and physician-reported data on the prevalence, severity, and treatment of moderate-to-severe chronic hand eczema (CHE). The data forms part of an expansive scientific program from LEO Pharma. Eight posters in total will be shared at the Eur
- Eczema Patients at Higher Risk for Comorbidities, Study Findshttps://practicaldermatology.com/news/eczema-patients-higher-risk-comorbidities-study-finds/2468064/Recent analysis of data from the NIH’s All of Us Research Program reveals significant associations between atopic dermatitis (AD) and other health conditions, underscoring the multifaceted burdens faced by AD patients. The All of Us Research Program, which collected health data from over 8